「evidence」の検索結果

Use for social science academic paper drafting, outlining, diagnosis, review, and revision. Trigger for topic diagnosis, research question refinement, literature review planning, CNKI/Google Scholar literature search-to-Zotero workflows, structured paper reading notes, theoretical framework design, research design critique, draft review, section or paragraph revision, citation and evidence risk checking, causal-claim checking, and pre-submission review. Do not use for purely creative writing or non-academic editing.

日本語の概要は準備中です。原文の説明を表示しています。

Polish, translate, diagnose, and restructure technical manuscript text into IEEE-style academic English using routed failure-mode guidance. Use for IEEE abstracts, introductions, related work, methods, experiments, conclusions, figure captions, rebuttals, Chinese-to-English technical writing, AI-like or template-like academic prose, and engineering prose that needs clearer problem logic, contribution framing, method rationale, evidence discipline, natural author voice, or reviewer-ready wording.

日本語の概要は準備中です。原文の説明を表示しています。

Verify a claim with fresh local evidence: restate it falsifiably, capture baseline and treatment, compare artifacts, and return VERIFIED, NOT VERIFIED, or INCONCLUSIVE.

日本語の概要は準備中です。原文の説明を表示しています。

Use Playwright CLI for ad hoc browser automation and interactive verification of Core UI: opening local routes, navigating, inspecting snapshots, using element refs, checking console/network activity, capturing evidence, tracing, and reproducing flows. Do not use it as a substitute for committed `@playwright/test` coverage or for non-browser unit tests.

日本語の概要は準備中です。原文の説明を表示しています。

Reconstruct evidence-based work descriptions and append user-confirmed durations to TIME.csv. Use for time logging and corrections; never infer hours or billing from activity.

日本語の概要は準備中です。原文の説明を表示しています。

Prepare a proportionate work plan with outcomes, steps, dependencies and acceptance evidence. Use to plan substantial work or coordinate an approved team; a plan-only request does not authorize implementation.

日本語の概要は準備中です。原文の説明を表示しています。

Capture one supplied product URL as auditable, unadopted FF&E evidence and inspect its retained history. Use to clip a page or review prior captures; not to save a library product or adopt a schedule item.

日本語の概要は準備中です。原文の説明を表示しています。

Audit a product, selection or FF&E schedule against sourced evidence and flag discrepancies, unknowns and stale specifications. Use to check product data; not to repair records, certify compliance or generate cut sheets.

日本語の概要は準備中です。原文の説明を表示しています。

Help users connect Arch Studio, understand its access and memory, choose a first workflow, and troubleshoot from reported evidence. General architecture and project execution stays with its owning skill.

日本語の概要は準備中です。原文の説明を表示しています。

Maintain an append-only project INVOICES.csv ledger from explicit billing facts and recorded lifecycle evidence; never infer charges or payment from activity or time logs.

日本語の概要は準備中です。原文の説明を表示しています。

Draft and register project proposals, protect issued terms, and record explicitly evidenced commercial lifecycle changes. Sending messages is separate authorization.

日本語の概要は準備中です。原文の説明を表示しています。

Extract countable FF&E or luminaire instances from supplied drawings with position-level evidence. Use for plan quantities or symbol counts; not area takeoffs, product specs or cross-source reconciliation.

日本語の概要は準備中です。原文の説明を表示しています。

Draft Project Manual specification requirements for EPD submittals and sourced GWP limits. Use for embodied-carbon requirements in project sections; use the EPD parsing, research or comparison skills for product evidence.

日本語の概要は準備中です。原文の説明を表示しています。

Query EBI QuickGO REST API for GO terms and protein annotations. Fetch term metadata by ID, search by keyword, walk ancestor/descendant hierarchies, download annotations filtered by taxon, evidence code, aspect. Use for GO resolution, ontology traversal, annotation retrieval before enrichment. Use gseapy-gene-enrichment for enrichment; uniprot-protein-database for proteins.

日本語の概要は準備中です。原文の説明を表示しています。

Cell type annotation strategy for scRNA-seq: name clusters manually from canonical markers, transfer labels from a reference (CellTypist, popV), or do both and validate one against the other. Covers matching tissue and developmental stage, marker evidence, annotation confidence, doublets, unresolved clusters. Use when planning or troubleshooting how to annotate cells.

日本語の概要は準備中です。原文の説明を表示しています。

Query RegulomeDB v2 GET REST API to score variants for regulatory function and retrieve overlapping evidence (TF binding, histone marks, DNase peaks, footprints, motifs, eQTLs, chromatin state). Scores range 1a (strongest) to 7 (none). Use for GWAS hit prioritization, regulatory variant annotation, cis-regulatory discovery. Use clinvar-database for pathogenicity; gwas-database for trait associations.

日本語の概要は準備中です。原文の説明を表示しています。

Query Open Targets GraphQL API for target-disease associations, evidence, drug links, safety. Search targets by gene, diseases by EFO ID; scores from 20+ sources, drug mechanisms, tractability. For ChEMBL use chembl-database-bioactivity; for trials use clinicaltrials-database-search.

日本語の概要は準備中です。原文の説明を表示しています。

Evaluating scientific evidence and claims. Covers study design hierarchy (RCT to expert opinion), effect sizes (OR, RR, NNT, Cohen's d), confounding, p-value vs clinical significance, GRADE quality assessment, reproducibility, and bias types (selection, information, confounding, reporting). Use when reading a paper or assessing claims.

日本語の概要は準備中です。原文の説明を表示しています。

Structured peer review of manuscripts and grants. 7-stage evaluation: initial assessment, section review, statistical rigor, reproducibility, figure integrity, ethics, writing. Covers CONSORT/STROBE/PRISMA and report structure. For evidence quality see scientific-critical-thinking; scoring see scholar-evaluation.

日本語の概要は準備中です。原文の説明を表示しています。

Guidelines for clinical decision support (CDS) documents: biomarker-stratified cohort analyses and GRADE-graded treatment reports. Covers structure, executive summaries, evidence grading (1A–2C), stats (HR, CI, survival), and biomarker integration. Use for pharma research docs, clinical guidelines, regulatory submissions.

日本語の概要は準備中です。原文の説明を表示しています。

Conducting systematic, scoping, and narrative literature reviews. Covers PRISMA/PRISMA-ScR protocols, search strategy (Boolean, MeSH), database selection (PubMed, Scopus, Web of Science, Embase), screening, data extraction, evidence synthesis (narrative, meta-analysis, thematic), and reporting. Use when planning or executing a formal literature review.

日本語の概要は準備中です。原文の説明を表示しています。

Verify a requested app flow or changed feature on an iOS simulator with UI evidence. Reuse a suitable session or set up mocks by default.

日本語の概要は準備中です。原文の説明を表示しています。

Use when about to claim a result, effect, significance, or that an analysis reproduces, before reporting or writing it up - requires running the analysis fresh and reading the actual output first; evidence before claims always

日本語の概要は準備中です。原文の説明を表示しています。

Canonical rules for preparing, opening, and updating Shift pull requests. Use whenever the user asks to create, open, draft, update, or review a pull request. Enforces issue discovery and linkage, Conventional Commit titles, release-note quality, complete validation evidence, and safe pushing.

日本語の概要は準備中です。原文の説明を表示しています。